SG Americas Securities LLC raised its holdings in Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 1,390.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 20,843 shares of the biotechnology company’s stock after acquiring an additional 19,445 shares during the period. SG Americas Securities LLC’s holdings in Axon Enterprise were worth $3,458,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also made changes to their positions in AXON. Capital International Investors increased its holdings in shares of Axon Enterprise by 605.2% during the 1st quarter. Capital International Investors now owns 2,660,634 shares of the biotechnology company’s stock worth $366,449,000 after buying an additional 2,283,343 shares during the last quarter. State Street Corp increased its holdings in shares of Axon Enterprise by 13.3% during the 1st quarter. State Street Corp now owns 2,220,692 shares of the biotechnology company’s stock worth $305,856,000 after buying an additional 261,508 shares during the last quarter. Neuberger Berman Group LLC increased its holdings in shares of Axon Enterprise by 65.5% during the 3rd quarter. Neuberger Berman Group LLC now owns 244,336 shares of the biotechnology company’s stock worth $28,282,000 after buying an additional 96,712 shares during the last quarter. Victory Capital Management Inc. increased its holdings in shares of Axon Enterprise by 78.6% during the 3rd quarter. Victory Capital Management Inc. now owns 196,462 shares of the biotechnology company’s stock worth $22,740,000 after buying an additional 86,442 shares during the last quarter. Finally, Castleark Management LLC acquired a new stake in shares of Axon Enterprise during the 3rd quarter worth $9,056,000. 75.62% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In related news, CEO Patrick W. Smith sold 53,683 shares of the stock in a transaction dated Monday, January 23rd. The shares were sold at an average price of $190.17, for a total transaction of $10,208,896.11. Following the sale, the chief executive officer now owns 2,475,880 shares in the company, valued at $470,838,099.60. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, CEO Patrick W. Smith sold 53,683 shares of the stock in a transaction dated Monday, January 23rd. The shares were sold at an average price of $190.17, for a total transaction of $10,208,896.11. Following the sale, the chief executive officer now owns 2,475,880 shares in the company, valued at $470,838,099.60. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Patrick W. Smith sold 96,575 shares of the stock in a transaction dated Friday, January 27th. The stock was sold at an average price of $190.49, for a total transaction of $18,396,571.75. Following the sale, the chief executive officer now owns 2,748,153 shares in the company, valued at approximately $523,495,664.97. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 350,688 shares of company stock worth $69,427,664. 6.90% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
AXON has been the subject of a number of research reports. The Goldman Sachs Group initiated coverage on shares of Axon Enterprise in a research report on Tuesday, March 7th. They set a “buy” rating and a $263.00 price target for the company. Barclays upped their price target on shares of Axon Enterprise from $177.00 to $222.00 and gave the stock an “overweight” rating in a research report on Thursday, March 2nd. Needham & Company LLC reaffirmed a “buy” rating and set a $240.00 price target on shares of Axon Enterprise in a research report on Thursday, April 13th. Craig Hallum upped their price target on shares of Axon Enterprise from $215.00 to $242.00 in a research report on Wednesday, March 1st. Finally, Raymond James cut shares of Axon Enterprise from a “strong-buy” rating to an “outperform” rating and set a $223.00 price target for the company. in a research report on Friday, February 17th. Three equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $227.36.
Axon Enterprise Stock Performance
Shares of Axon Enterprise stock opened at $225.02 on Friday. The firm has a market cap of $16.62 billion, a PE ratio of 110.30 and a beta of 0.95. The firm’s 50-day simple moving average is $214.39 and its 200-day simple moving average is $186.82. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.66 and a current ratio of 3.00. Axon Enterprise, Inc. has a 1 year low of $82.49 and a 1 year high of $229.00.
Axon Enterprise Profile
Axon Enterprise, Inc engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Axon Enterprise wasn’t on the list.
While Axon Enterprise currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
